Mirati Therapeutics, Inc.
Open: 3:25 PM
MRTX Stock Price Graph
MRTX Stock Price Today
Mirati Therapeutics, Inc. (MRTX) stock rallied over 0.21% intraday to trade at $57.08 a share on NASDAQ. The stock opened with a loss of -2.36% at $55.41 and touched an intraday high of $55.53, rising 0.58% against the last close of $56.75. The Mirati Therapeutics, Inc. in stock market went to a low of $55.14 during the session.
MRTX Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
MRTX Stock Price History Chart
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; and Sitravatinib, an investigational spectrum-selective kinase inhibitor that is in Phase 3 clinical trial for the treatment of NSCL cancer, as well as a KRAS G12D inhibitor program, which is in preclinical development. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.
Frequently Asked Questions
What is the current Mirati Therapeutics, Inc. (MRTX) stock price?
Mirati Therapeutics, Inc. (NASDAQ: MRTX) stock price is $57.08 in the last trading session. During the trading session, MRTX stock reached the peak price of $55.53 while $55.14 was the lowest point it dropped to. The percentage change in MRTX stock occurred in the recent session was 0.21% while the dollar amount for the price change in MRTX stock was $0.12.
MRTX's industry and sector of operation?
The NASDAQ listed MRTX is part of Biotechnology industry that operates in the broader Healthcare sector. Mirati Therapeutics, Inc. , a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States.
Who are the executives of MRTX?
Mr. Ryan Asay
Vice President & Head of Corporation Affairs
Dr. Kelly Covello Ph.D.
Vice President & Head of Medical Affairs
Dr. Alan Bart Sandler M.D.
Executive Vice President & Chief Medical Officer
Ms. Reena R. Desai
Chief Legal Officer & Corporation Sec.
How MRTX did perform over past 52-week?
MRTX's closing price is 0.37% higher than its 52-week low of $27.3 where as its distance from 52-week high of $101.3 is -0.56%.
How many employees does MRTX have?
Number of MRTX employees currently stands at N/A. MRTX operates from 3545 Cray Court, San Diego, CA 92121, US.
Link for MRTX official website?
Official Website of MRTX is: https://www.mirati.com
How do I contact MRTX?
How many shares of MRTX are traded daily?
MRTX stock volume for the day was 989970.00 shares. The average number of MRTX shares traded daily for last 3 months was 2.24 Million.
What is the market cap of MRTX currently?
The market value of MRTX currently stands at $4 Billion with its latest stock price at $57.08 and N/A of its shares outstanding.